Skip to content
Screener

Dermata Therapeutics, Inc. DRMA Q4 2025 Annual earnings

Reported March 26, 2026 · Before market open

EPS-$1.52Beat by $0.02
EPS estimate-$1.54

Next report

Nov 18, 2026 (in 3 months)
Revenue estimate$25.0K
EPS estimate-$0.55

FAQ

When did Dermata Therapeutics, Inc. report Q4 2025 earnings?
Dermata Therapeutics, Inc. (DRMA) reported Q4 2025 earnings on March 26, 2026 before market open.
What were Dermata Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Dermata Therapeutics, Inc. reported eps of $-1.52 for Q4 2025.
Did Dermata Therapeutics, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-1.54 by $0.02.
How did Dermata Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 51.7% from $-3.15.
Where can I find Dermata Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-012991) and the 10-K periodic report (0001493152-26-012992) directly on SEC EDGAR. The filing index links above go to sec.gov.